InsidersTradesSigma
Total declarations
Company
▲ Purchases (25 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
25
Disclosed sells
0
T+90 hit rate
58%
T+90 mean return
+28.7%
Across 19 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Young Caroline, Director. Officer active across 1 company, notably Cumberland Pharmaceuticals INC. Cumulatively, 46 filings have been logged. Breakdown: 25 buys · 0 sell. Total volume traded: €912. Activity tracked since 17 March 2021. The latest transaction was filed on 18 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Young Caroline
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations46 total
1,800 shares@ US$2.8018.9% of flowCommon StockSEC:0001087294-26-000036:0
4 shares@ US$2.360.0% of flowCommon StockSEC:0001087294-26-000008:0
6 shares@ US$2.800.1% of flowCommon StockSEC:0001087294-25-000029:0
6 shares@ US$3.310.1% of flowCommon StockSEC:0001684087-25-000008:0
4 shares@ US$3.540.1% of flowCommon StockSEC:0001684087-25-000004:0
6 shares@ US$3.440.1% of flowCommon StockSEC:0001628280-25-041989:0
Canonical exit: 30 Oct 2025 (T+90)
8 shares@ US$3.560.1% of flowCommon StockSEC:0001628280-25-039411:0
Canonical exit: 29 Sept 2025 (T+90)
4 shares@ US$5.200.1% of flowCommon StockSEC:0001628280-25-034820:0
Canonical exit: 31 Aug 2025 (T+90)
4 shares@ US$4.860.1% of flowCommon StockSEC:0001628280-25-029852:0
Canonical exit: 30 Jul 2025 (T+90)
4 shares@ US$4.240.1% of flowCommon StockSEC:0001628280-25-024355:0
Canonical exit: 30 Jun 2025 (T+90)
4 shares@ US$5.540.1% of flowCommon StockSEC:0001628280-25-016745:0
Canonical exit: 1 Jun 2025 (T+90)
1,000 shares@ US$5.1721.9% of flowCommon StockSEC:0001628280-25-013548:0
2,500 shares@ US$1.7118.2% of flowCommon StockSEC:0001628280-25-003181:0
15 shares@ US$1.330.1% of flowCommon StockSEC:0001628280-24-052610:0
Canonical exit: 2 Mar 2025 (T+90)
38 shares@ US$1.150.2% of flowCommon StockSEC:0001628280-24-050113:0
Canonical exit: 30 Jan 2025 (T+90)
31 shares@ US$1.270.2% of flowCommon StockSEC:0001628280-24-045334:0
Canonical exit: 30 Dec 2024 (T+90)
25 shares@ US$1.380.1% of flowCommon StockSEC:0001628280-24-042124:0
21 shares@ US$1.470.1% of flowCommon StockSEC:0001214659-24-016075:0
21 shares@ US$1.470.1% of flowCommon StockSEC:0001214659-24-016035:0
21 shares@ US$1.470.1% of flowCommon StockSEC:0001214659-24-013685:0
25 shares@ US$1.520.2% of flowCommon StockSEC:0001214659-24-011873:0
1,000 shares@ US$1.717.3% of flowCommon StockSEC:0001214659-24-005221:0
72 shares@ US$1.690.5% of flowCommon StockSEC:0001214659-23-017033:0
55 shares@ US$1.850.4% of flowCommon StockSEC:0001214659-23-016104:0
55 shares@ US$1.890.5% of flowCommon StockSEC:0001214659-23-014544:0
25 of 46 declarations
About Young Caroline
Young Caroline is Administrateur at Cumberland Pharmaceuticals INC (XNAS). She has 46 filings in total, and across the 46 sampled filings the transactions are acquisitions, with total buy volume of EUR 912 and no sales, between 2021-06-11 and 2026-03-20.
